During the past decade, University Hospital Zurich, Division of Neurology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Zurich, Division of Neurology" #1 sponsor was "University of Zurich" with 17 trials, followed by "Christian Baumann" with 5 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Midnight Pharma, LLC" with 2 trials sponsored and "D-Pharm Ltd." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Zurich, Division of Neurology" #1 collaborator was "Swiss National Science Foundation" with 4 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "ETH Zurich" with 1 trials as a collaborator, "Klinik Lengg AG" with 1 trials as a collaborator and "Schweizerische Herzstiftung" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Zurich, Division of Neurology" are "Glioblastoma" (2 trials), "Health Behavior" (2 trials), "Narcolepsy" (2 trials), "Parkinson Disease" (2 trials) and "Primary Insomnia" (2 trials). Many other conditions were trialed in "University Hospital Zurich, Division of Neurology" in a lesser frequency.

Most popular intervention types in "University Hospital Zurich, Division of Neurology" are "Drug" (16 trials), "Other" (5 trials), "Behavioral" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abciximab" (2 trials), "Bevacizumab" (2 trials), "almorexant" (2 trials) and "4x4 min HIT" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Zurich, Division of Neurology" are 24 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Zurich, Division of Neurology". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University Hospital Zurich, Division of Neurology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Zurich, Division of Neurology, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".